Danimer Scientific, Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020
Assets:
Current assets:
Cash and cash equivalents
Restricted cash, current
Accounts receivable, net
Income tax receivable, net
Other receivables, net
Inventories, net
Prepaid expenses and other current assets
Contract assets, net
Total current assets

Cash and marketable securities held in Trust Account
Property, plant and equipment, net
Intangible assets, net
Goodwill
Right-of-use assets
Leverage loans receivable
Restricted cash
Loan fees
Other assets
Total assets

Liabilities and Stockholders' equity:
Current liabilities:
Accounts payable
Accrued liabilities
Unearned revenue and contract liabilities
Deferred Revenue
Current portion of lease liability
Current portion of long-term debt, net
Total current liabilities
Deferred underwriting fee payable
Long-term lease liability, net
Long-term debt, net
Deferred income taxes
Warrants liability
Other long-term liabilities
Total liabilities
Class A Common stock subject to possible redemption, 18,976,181, shares at $10.00 per share
Class A Common Stock
Total class A Common stock subject to possible redemption, 18,976,181, shares at $10.00 per share
Stockholders’ equity:
Common stock, $0.0001 par value; 600,000,000 shares authorized: 120,771,640 and 102,832,103 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively
Class A Common Stock
Class B Common Stock
Total common stock, $0.0001 par value; 600,000,000 shares authorized: 120,771,640 and 102,832,103 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively

Additional paid-in capital
Accumulated deficit
Class A Common Stock
Class B Common Stock
Total stockholders’ equity

Total liabilities and stockholders’ equity

Comments